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Abstract
Background: Wireless esophageal pH monitoring system is an important approach for diagnosis of gastroesophageal
reflux disease (GERD), the aim of this study is to test the tolerability and utility of the first wireless esophageal pH
monitoring system made in China, and evaluate whether it is feasible for clinical application to diagnose GERD.
Methods: Thirty patients from Department of Gastroenterology of The First Affiliated Hospital of Chongqing Medical
University who were suspected GERD underwent JSPH-1 pH capsule. The capsule was placed 5 cm proximal to the
squamocolumnar junction (SCJ) by endoscopic determination, the data was recorded consecutively for 48 hours. Then
all pH data was downloaded to a computer for analysis. The discomforts reported by patients were recorded.
Results: 30 patients were placed JSPH-1 pH capsule successfully and completed 24-hour data recording, 29 patients
completed 48-hour data recording. One patient complained of chest pain and required endoscopic removal. No
complications and interference of daily activities were reported during data monitoring or follow-up period. 48-hour
pH monitoring detected 15 patients of abnormal acid exposure, on day1 detected 9 patients, the difference had
statistical significance (P<0.01). Positive symptom index (SI) was identified in 3 patients with normal pH data in both
24-hours. In total, 48-hour monitoring increased diagnosis of GERD in 9 patients.
Conclusion: 48-hour esophageal pH monitoring with JSPH-1 wireless pH monitoring system is safe, well tolerated and
effective. It can be feasible for clinical application to diagnose GERD.
Keywords: Esophagus, Abnormal acid exposure, Esophageal pH monitoring, Wireless pH monitoring system,
Gastroesophageal reflux disease
Background
In western countries, the prevalence of GERD is approxi-
mate 10%-20% [1] and has the trend of ascendant. In re-
cent decades, several population-based studies have shown
that the prevalence of GERD has significantly increased in
Asia [2]. GERD has gradually become one of the most
common upper gastrointestinal disorders. Patients are
suffering from acid reflux, life and health are seriously
impacted. So the diagnosis of GERD seems more and more
important. Currently, the main approaches for diagnosis of
GERD include endoscopy, symptom questionnaire (such as
gastroesophageal reflux disease questionnaire), diagnostic
testing with proton pump inhibitor (PPI), gastroesophageal
reflux monitoring (esophageal pH monitoring, esophageal
impedance monitoring, esophageal pressure monitoring,
high-frequency endo-luminal ultrasound, esophageal
bilirubin reflux monitoring) and so on. Esophageal pH
monitoring serves an important role in numerous meth-
ods, because it can quantify esophageal acid exposure and
provide objective pH data for diagnosis. Ambulatory
esophageal pH monitoring involves an electrode in a cath-
eter, and can transnasally into the esophagus, but the cath-
eter causes pharyngeal, nasal, oral discomfort, and social
embarrassment. Consequently, patients would like to keep
more sedentary during monitoring period, and modify
normal activities/or diet which may provoke acid reflux
[3,4]. In addition, movement of catheter can lead electrode
off the primary position. All of this can result in inaccurate
pH data and final diagnosis.
With Technologic advances, wireless pH monitoring
system has been introduced into clinical application.
The Medtronic Bravo pH monitoring system was the
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United States Food and Drug Administration class I
approved wireless pH monitoring system [5], this system
includes a radiotelemetry pH capsule attached to the
mucosal wall of esophagus, which simultaneously mea-
sures pH (frequency is 6 s) and transmits (frequency is
75 s) data to a wireless data receiver, that can decrease
discomfort and social inconvenience, patients could bet-
ter tolerate and keep normal daily activities easily [5,6].
Moreover, wireless pH capsule can decrease false-
negative results. Many authors have confirmed the clin-
ical utility and tolerability of wireless pH monitoring
system [7-10]. Recently, a study also showed wireless pH
capsule provided new information altering patient man-
agement and changing patient diagnoses [11].
JSPH-1 wireless pH monitoring system is designed by
Jinshan Science and Technology Inc. of Chongqing in
China. With examination and approval of Ethical Com-
mittee of the First Affiliated Hospital of Chongqing Med-
ical University in China, we performed a clinical test to
confirm the sWith examination and approval of Ethical
Committee of the First Affiliated Hospital of Chongqing
Medical University in China, we performed a clinical test
to confirm the safety, tolerance, and clinical utility of this
new wireless pH monitoring system and to evaluate
whether it is feasible for clinical application.afety, toler-
ance, and clinical utility of this new wireless pH monitor-




Materials of the JSPH-1 pH wireless monitoring sys-
tem include a capsule, a delivery device and a wireless
data receiver (Figure 1), a capsule by the size of
26.5 mm×6.0 mm×5.5 mm, the container constructed
with acid–resistant and alkali–resistant material, con-
taining an antimony pH electrode, a silver oxide internal
battery, a radio transmitter and a clipping device (Figure 2).
The antimony pH electrode is hypersensitive to acid, but
it also can respond to alkaline. The pH sensor detects pH
data every 3 s and transmits to wireless receiver by the
radio transmitter every 60s, and the silver oxide battery
enables 96-hour or longer pH-metry. In proximal of the
capsule, there is a hole with an opening electrical insulat-
ing clip. When the clip closed, capsule would be fixed on
esophageal mucosa wall.
Three movable buttons marked 1, 2, 3 are lined on the
handle of delivery device (Figure 2). Firstly, sliding the
button marked number 1 to the end of proximal rail can
close the clip. Then, sliding the button marked number
2 can release the clip from delivery device. At last, slid-
ing the button marked number 3 releases the whole cap-
sule from the delivery device. The three buttons must be
slid in turn to avoid laceration of esophageal mucosa,
severe ache or huge hemorrhage and ensure a safe
process of capsule placement.
Patients screening
With examination and approval of Ethical Committee of
The First Affiliated Hospital of Chongqing Medical Uni-
versity in China, we performed a prospective clinical test.
All patients gave their written informed consent to partici-
pate and the study was conducted in accordance with the
Declaration of Helsinki. Patients came from Department
of Gastroenterology of First Affiliated Hospital of
Chongqing Medical University from April 2011 to
August 2011, aged 18 to 65 years, with typical symp-
toms (heartburn, regurgitation) and/or atypical symp-
toms (chest pain, asthma and chronic cough with no
reason, chronic pharyngitis) of GERD, or PPI therapy
test positive were fit for inclusion. Exclusion criteria of
this study were: pregnant women, with history of bleed-
ing tendency or coagulation function abnormal, proximal
esophagus or nasopharynx suspect obstruction, significant
erosive of esophageal mucosa, a history of upper gastro-
intestinal surgery within 6 months, gastroenteric obstruc-
tion, uncooperative patients, or hypersensitivity to the
material. All patients provided basic information and
disease history, and were requested to be off antacids
for 24 hours as well as histamine-2 receptor antagonists
for at least 5 days. PPI should be stopped for 7 days.
Fasting state with nothing taking should continue at
least 6 hours prior to the study. All patients signed
informed consents file before the test.
Protocol taking
Before placement, pH capsule was put into the buffer
solution with different pH (1.07, 4.00 and 7.01) for cali-
bration, this procedure was finished in Motility Labora-
tory. Then patients were taken to endoscopic room,
underwent endoscopy to measure the accurate position
of SCJ and detect esophageal lesions. All patients were
Figure 1 (Color graph) JSPH-1pH capsule system: delivery
system, capsule and wireless receiver.
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kept conscious without sedation in the whole process.
When JSPH-1 capsule reached posterior wall of orphar-
ynx, patients coordinated swallowing act to assist the
capsule enter into esophagus. Paid attention to the scales
on the delivery catheter when the catheter slowly trans-
mitted into esophagus, make sure the pH capsule was
placed 5 cm above SCJ (Figure 3). Subsequently, con-
nected vacuum pump to the handle, turned on it to
apply suction pressure stabilized at 550 mmHg for 5 s,
the adjacent esophageal mucosa was immediately drawn
in. Sliding the movable button marked number 1 to the
end of proximal rail to close the clip around the drawn
mucosa immediately, thus attaching the capsule to
esophageal mucosa wall. The button marked number 2
was slid to release the clip from the delivery catheter,
the button number 3 release the capsule from the deliv-
ery system. Finally, turned off the vacuum pump,
removed it from the handle and took out the delivery
catheter slowly. The attached capsule would be checked
directly by endoscopy. Patients were told to take the
wireless data receiver in the pockets or bags, with the
distance no more than 2 meters at any time during
recording period. Patients were encouraged to keep nor-
mal daily activities except for alcohol or carbonic acid
beverage drinking. The drugs which influenced acid
reflux were not permitted. Instructions about keeping
detail dairy were performed, dairy including daily activ-
ities, food taking, reflux symptoms(chest discomfort,
acid reflux, heart burn)and other events which would be
useful in the later interpretation of pH data. Patients
were informed to return 24 hours latter, at that time the
data would be downloaded to a computer for primary
analysis. All patients underwent chest X-ray to docu-
ment capsule attachment, if pH capsule was detached,
the patients would exit the later study. Others took back
the diary for continue recording in another 24 hours.
48 hours later, all patients turned in receivers and diar-
ies. All sufficient data was downloaded to a computer
and automatically analyzed by Jin Shan pH monitoring
working station. All pH data was provided along with
pH tracings of day1,day2 and the 48-h test period.
Follow-up time would last for 3 months after capsule
detachment.
catheter Release device   pH capsule
Capsule power switch
Button  Button  Button









Figure 2 (A)Prepackaged device including both a delivery system and a capsule, unit of length is millimeter (mm). (B) Separated
handle of the delivery system and JSPH-1 pH capsule for detail introduction.
Figure 3 Capsule was placed 5-cm above SCJ and was
confirmed by endoscopy.
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Data analysis
The pH data recording time continues at least 24 hours
was available, less than 24 hours considered insufficient.
If the pH data sudden dropped to below 2 (pH < 2) for
more than 2 hours (in stomach), then pH data rise to
normal, no longer fall in remain trial (in small bowel). In
this phenomenon, the capsule was considered detached,
if it was confirmed by X ray, the data was deemed
invalid (Figure 4).
Johnson-DeMeester score [12,13] was used to evaluate
abnormal acid exposure, the score greater than 14.7
defined abnormal acid exposure positive [14]. SI was
used to express symptom-reflux associations. The values
more than 50% were considered positive [15,16]. The
software of SAS 9.2 was used to carry out all the analysis
needed in our study.
Results
Originally, thirty-two patients were preliminary
screened. One patient requested to exit due to distant
residence. Another one was excluded because of severe
arrhythmia. The rest of the 30 patients were finally
selected (Table 1), 19 female (63.3%), 11male (37.7%),
median of age 47.0. The attachment confirmed by
endoscopy was successful in all patients.
During placement process, 26 patients had mild
discomfort with slight nausea. Eighteen patients (60%)
had symptoms related to capsule attachment, no patient
had nausea. Symptoms related to capsule attachment
were: foreign body sense in 12(40%), chest pain in 10
(33%), dysphagia in 8(27%), and 5(17%) had more than
one symptom. Those symptoms disappeared when
capsule was dislodged (Table 2).
We detected capsules detachment by pH data or docu-
mented by X-ray. In 28 patients (93.3%), capsules
dislodged within 4 to 12 days, 1 patient at 27th hour and
1 patient almost at 25th day. Capsules spontaneously
dislodged in 29 patients. 1 patient complained of chest
pain, and we performed endoscopic removal on 7th day
according to her requirement. No one complained of
discomfort or limitation of daily life during detachment
and excretion of the capsule or in follow-up period
(Figure 5).
Effective pH monitoring extended 48 hours in 29
patients (96.7%). Abnormal acid exposure occurred in 9
patients (30.0%) on day1, 12 patients (41.4%) on day2,
and 15 patients (51.7%) in extended 48-h. the difference





Figure 4 Premature detachment of JSPH-1 pH capsule in our study (n=1). The sudden prolonged dropped in pH represented pH capsule
detached into stomach, and then sharp raised when the capsule entered the small intestine. The data following capsule detached were invalid.
Table 1 Patient characteristics












(Chest pain or abdominal distention)
Table 2 Severity of symptoms related to attachment of
JSPH-1
Chest pain Foreign Body Dysphagia
(n, %) Sensation (n, %) (n, %)
Mild 8(80%) 7(58%) 5(63%)
Moderate 1(10%) 5(42%) 3(27%)
Severe 1(10%) 0 0
Very severe 0 0 0
*n represents the number of patients.
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48-h and day1 (P=6.997E-04), also between 48-h and
day2 (P=1.052E-05) (Table 3).
In total, 26 patients reported symptoms of GERD. SI
was positive in 9 patients (31.0%) in day1, 11 patients
(37.9%) day2, 19 patients (65.5%) in 48-h.The difference
of SI had statistical significance between the 48-h and
day1 (P=0.0114), but no statistical significance between
48-h and day 2 (P=0.2344) (Table 4).
Six patients had been identified during 48-h with
abnormal pH data but not been detected on day1. In 14
patients (46.7%) with normal pH data on both day1 and
day2, positive SI was identified in 3 patients (21.4%).
Figure 5 Correct capsule position in patients, forty-eight-hour pH tracings using Jinshan pH monitoring working station. (A) A normal
subject. (B) A GERD patient with slight reflux. (C) A GERD patient with serious reflux.
Table 3 The result of abnormal acid exposure in 48-h,
day1 and day2
24-h (n, %) 48-h (n, %) P
day1 9(31.0%) 15(65.5%) 6.997E-04
day2 12(37.9%) 15(65.5%) 1.052E-05
*n represents the number of patients with abnormal acid exposure positive.
Table 4 The result of SI in 48-h, day1 and day2
24-h (n, %) 48-h (n, %) P
day1 9(31.0%) 19(65.5%) 0.0114
day2 11(37.9%) 19(65.5%) 0.2344
*n represents the number of patients with positive SI.
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therefore, 48-h extended monitoring increased 9 patients
(31.0%) diagnosis of GERD.
Discussion
As far as our knowledge goes, this is the first clinical test
based on a new wireless pH monitoring system made in
China. The JSPH-1 pH capsule was designed with a high
monitoring frequency of 3 s, transmission frequency of
60s, working hour extends to 96 hours, and pH value
can be detected from 0 to 9, the measure accuracy reach
±0.5. That may be advanced when evaluate sensitivity
and diagnostic yield in patients with an indeterminate
result for GERD after 48-h or 24-h pH monitoring
[17,18]. Because of high working efficiency and long
working hours, JSPH-1 new pH monitoring system can
detect extremely slight abnormal esophageal acid expos-
ure, and observe clinical effect of anti-acid reflux medi-
cine. It is still unknown whether JSPH-1 pH capsule is
more effective than BRAVO pH capsule system in clin-
ical complication.
Foreign body sensation in this study was the most
common symptom reported by patients, similar results
were showed in some studies based on Bravo pH capsule
system [5,19]. Endoscopic removal should be performed
when patients have serious symptoms for more than
48 hours [20] or capsule was still attached for more than
two weeks. A cold snare would be used to loosely
around the base of the attachment area between the cap-
sule and the esophageal mucosa, then gently pulled the
snare to-and-fro, if the capsule fails to detached, closing
the snare, with the position as close to the base of cap-
sule as possible, and then the hot snare mode should be
promoted to cut the attachment mucosa successfully. In
our study, 1 patient (female) reported chest pain during
data monitoring with depressive and nervous emotion.
The pathological mechanism of chest pain might be con-
nected to hypertensive esophageal contractions caused
by intraesophageal capsule [21]. But in our study,
depressive emotion might be also an important factor.
Many studies based on BRAVO pH capsule system had
showed extended 48-h pH monitoring increased diagnosis
of GERD [22,23]. A retrospective study [19] with 100
patients performed BRAVO pH capsule system confirmed
48-h extended monitoring detected 43.4% more patients
with abnormal esophageal acid exposure. With JSPH-1 pH
capsule, extended 48-h pH monitoring also seems more
sensitive than 24-h monitoring because 48-h pH monitor-
ing increased 6 patients (21.7%) detection of abnormal
esophageal acid exposure when compared to day1, and
increased 3 patients (10.3%) detection when compared to
day 2. If monitoring time was 24-h or analysis only 24-h
pH data, these patients would have been misdiagnosed.
Positive SI was identified in 3 patients out of 14 patients
with normal pH data, According to Rome III criteria, these
patients should be included in GERD disease [24,25]. In
total, extended 48-h pH monitoring increased 9 patients
(31.0%) diagnosis of GERD when 24-h pH monitoring data
could not make diagnosis [19], but the increased rate was
lower than the result with BRAVO pH capsule system.
Some study demonstrated 48-hour pH monitoring
increases the risk of false positive studies when the capsule
is prematurely dislodged [26], in our study, the capsule
prematurely dislodged at 27th hour occurred in 1 patient,
the data was excluded on day 2 to avoid the false positive.
48-h pH monitoring detect positive SI more than
day1, the difference had statistical significance. There-
fore, 48-h extended monitoring could increase diagnosis
of GERD according to abnormal pH data and SI.
Wireless pH monitoring systems are favorable for
diagnosis of GERD, but also have common disadvantages
[25]: proximal esophageal reflux monitoring is not feas-
ible, non-acid reflux can not be evaluated. Multichannel
intraluminal impedance-pH (MII-pH) testing [27,28] is a
relatively new technique, it can detect non-acidic reflux
episodes through changes of impedance in esophageal
lumen, especially air reflux episodes when pH data is
normal. If JSPH-1 pH capsule system introduces an
impedance electrode in container on the basis of fitful or
smaller measure of capsule which would be a great
improvement in diagnostic field of GERD.
Although our study had been designed carefully, sev-
eral limitations to this study should be mentioned.
Firstly, all of the subjects were endoscopy normal
patients with acid reflux symptoms, the major pathme-
chanism related with esophageal mucosal hypersensitiv-
ity, the discomfort of pH capsule attachment in
monitoring time might be amplified. Secondly, the study
was not designed to compare with other wireless sys-
tems directly. It is still unknown whether JSPH-1 pH
capsule is more effective than other wireless systems in
clinical complication or not. Thirdly, our study was a
small sample clinical test carried out in a single center,
the data could provide valid information but the result
might be with fairly error, thus, a large and multiple cen-
ters with prospective study with JSPH-1 pH capsule will
be needed in the future.
Conclusions
JSPH-1 pH capsule system is a new wireless esophageal
pH monitoring system with high working efficiency, high
accuracy and long working hour. In this clinical test,
patients underwent JSPH-1 pH capsule have a well toler-
ance in the whole procedure, no interference in their
daily activities. 48-h extended pH monitoring increased
in diagnostic field of GERD. Consequently, JSPH-1 pH
capsule system is safe, well tolerant and effective. It can
be feasible for clinical application to diagnose GERD.
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